搜索临床试验以:Boceprevir、聚乙二醇干扰素 alfa 2b 和利巴韦林
总计1262个结果
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Shanghai General Hospital, Shanghai Jiao Tong University...完全的
-
Merck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLC撤销
-
Emory UniversityCURE Childhood Cancer, Inc.完全的
-
Kaohsiung Medical University Chung-Ho Memorial...完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Centre hospitalier de l'Université de Montréal...Hoffmann-La Roche; Centre de Recherche du Centre Hospitalier de l'Université de Montréal完全的
-
Casa Sollievo della Sofferenza IRCCS完全的
-
Merck Sharp & Dohme LLC终止
-
National Taiwan University HospitalNational Science Council, Taiwan未知
-
Hepatitis Resource NetworkIntegrated Therapeutics Group; Subsidiary of Schering-Plough完全的
-
Theodor Bilharz Research Institute未知Genotype 4 Chronic Hepatitis C Infection埃及
-
M.D. Anderson Cancer CenterSchering-Plough终止
-
The First Hospital of Jilin UniversityChinese Academy of Sciences未知
-
Merck Sharp & Dohme LLCIntegrated Therapeutics Group撤销肝硬化 | 艾滋病毒感染 | 丙型肝炎
-
Merck Sharp & Dohme LLC完全的
-
NovartisHuman Genome Sciences Inc.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Biolex Therapeutics, Inc.完全的
-
Merck Sharp & Dohme LLC完全的药物滥用,静脉注射 | 丙型肝炎,慢性
-
PharmaEssentia完全的
-
Medtronic Corporate Technologies and New Ventures完全的
-
Kirby InstituteMerck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLC撤销
-
Kyoto University完全的
-
Anna Cruceta完全的艾滋病毒感染 | 丙型肝炎 | COINFECTION西班牙
-
French National Agency for Research on AIDS and...Schering-Plough终止
-
ANRS, Emerging Infectious DiseasesRoche Pharma AG完全的
-
California Cancer ConsortiumNational Cancer Institute (NCI)终止
-
Ochsner Health SystemNewLink Genetics Corporation未知
-
Merck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLCBioikos Ambiente Srl完全的
-
Merck Sharp & Dohme LLC完全的